Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2017-002223-25Phase 4Active
Phase 4 trial of coal tar in atopic dermatitis (AD) (2 arms), sponsored by Radboud University Medical Center. Primary endpoint: Skin barrier repair and function. Started Apr 2018; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2017-002223-25.